Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics

ACS Chemical Neuroscience - Tập 8 Số 7 - Trang 1570-1576 - 2017
Jessica Raper1, Ryan D. Morrison2, J. Scott Daniels2, Leonard L. Howell3,4, Jocelyne Bachevalier5,6, Thomas Wichmann7,8,9, Adriana Galván7,8,9
1Yerkes National Primate Research Center, Atlanta, Georgia 30329, United States
2Sano Informed Prescribing, Inc. Franklin, Tennessee 37067, United States
3Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia 30322, United States
4Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia 30322, United States; Yerkes National Primate Research Center, Atlanta, Georgia 30329, United States
5Department of Psychology, Emory University, Atlanta, Georgia 30322, United States
6Department of Psychology, Emory University, Atlanta, Georgia 30322, United States; Yerkes National Primate Research Center, Atlanta, Georgia 30329, United States
7Department of Neurology, School of Medicine, Emory University, Atlanta, Georgia 30322, United States
8Department of Neurology, School of Medicine, Emory University, Atlanta, Georgia 30322, United States; Yerkes National Primate Research Center, Atlanta, Georgia 30329, United States
9Udall Center of Excellence for Parkinson’s Disease Research, Emory University, Atlanta, Georgia 30329, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/j.brainres.2012.09.043

10.1073/pnas.0700293104

10.1016/j.neuron.2016.01.040

10.1037/bne0000135

10.1016/j.tips.2013.04.006

10.1146/annurev-pharmtox-010814-124803

10.1124/pr.110.003020

10.1038/nn.4192

10.1016/j.neuron.2016.06.005

10.1038/ncomms13605

10.1016/S0278-5846(98)00035-9

Jann M. W., 1994, Arch. Int. Pharmacodyn. Ther., 328, 243

10.1523/ENEURO.0219-16.2016

10.1038/nature11052

10.1002/prp2.77

10.1124/jpet.107.130294

10.2174/138920007780655423

10.1124/dmd.111.043703

10.1021/acschemneuro.6b00024

Bauer B., 2005, Exp Biol. Med. (Maywood), 230, 118, 10.1177/153537020523000206

10.1016/j.tips.2010.03.003

10.1007/s40262-015-0310-2

Bickel M. H., 1969, Pharmacol Rev., 21, 325

10.1016/j.pharmthera.2007.05.004

Roth B. L., 2014, Psychoactive Drug Screening Program

10.1016/0014-2999(90)94100-C

10.1016/0165-6147(94)90323-9

10.1038/jcbfm.2012.126

10.1021/cn500325v

10.1016/j.psyneuen.2012.10.008

10.1523/JNEUROSCI.0269-14.2014

10.1124/dmd.106.012294